Skip to content

META Arabic logo

Main menu
    • من نحن؟
      • رؤيتنا ورسالتنا وقيمنا
      • التنوع والمساواة والدمج
      • قادتنا
      • أعضاء مجلس الإدارة
      • فريق الإدارة التنفيذية
    • البيئة والمجتمع والحوكمة
    • السياسات والمواقف
    • موردينا
    • الإعلام
    • المقالات الصحفية
    • حقك تقرري
    • نظرة عامة على علاقات المستثمرين
    • إيداعات SEC
  • انضم إلى فريقنا

للتواصل معنا

Main menu

Organon site directory

  • Organon

    • Brazil
    • Canada  English  ·  French
    • Latin America
    • Mexico
    • USA
  • Organon

    • Austria
    • Belgium  Dutch  ·  English  ·  French
    • Bulgaria
    • Czech Republic
    • Denmark
    • Estonia
    • Finland
    • France
    • Germany
    • Hungary
    • Ireland
    • Italy
    • Latvia
    • Lithuania
    • Luxembourg  English  ·  French
    • Netherlands  Dutch  ·  English
    • Norway
    • Poland
    • Portugal
    • Romania
    • Russia
    • Serbia
    • Slovakia
    • Slovenia
    • Spain
    • Sweden
    • Switzerland  French  ·  German  ·  English
    • Ukraine  Ukrainian  · 
    • United Kingdom
  • Organon

    • Australia
    • Hong Kong, China
    • Indonesia
    • Japan
    • Malaysia
    • New Zealand
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Organon

    • Egypt
    • Israel
    • Jordan
    • KSA
    • Kuwait
    • Lebanon
    • Northwest Africa  French  ·  Arabic  ·  Turkey
    • Oman
    • South Africa
    • Turkey
    • UAE
View all locations and contact information

What can we help you find?

Search for:

فريق القيادة التنفيذية

يدير فريقنا التنفيذي التوجه الاستراتيجي وعمليات شركتنا. من خلال تجاربهم الواسعة والمتنوعة ، فإنهم يوجهون من نحن وماذا نمثل.

Photo of كيفن علي

كيفن علي

Photo of سوزان فيدلر

سوزان فيدلر

Photo of خوان كاميلو أرجونا فيريرا

خوان كاميلو أرجونا فيريرا, رئيس قسم البحث والتطوير وكبير المسؤولين الطبيين

Photo of جوزيف موريسي

جوزيف موريسي

Photo of فيتوريو نيسيتا

فيتوريو نيسيتا

Photo of آرون فالسيون

آرون فالسيون

Photo of ماثيو والش

ماثيو والش

Photo of راشيل ستالر

راشيل ستالر

Photo of كيرك ويفر

كيرك ويفر, المستشار العام وأمين سر الشركة

Photo of توم ميريام

توم ميريام, رئيس إستراتيجية الشركة وكبير الموظفين

META Arabic logo

شركة

  • من نحن؟
  • قادتنا
  • البيئة والمجتمع والحوكمة

موارد

  • موارد المريض
  • علاقات المستثمرين
  • الإعلام

اتصل بنا

  • اتصل بنا
  • معلومات للتواصل
  • المواقع العالمية
  • بيان تطلعي
  • سياسة ملفات الارتباط
  • سياسة خاصة
  • تعليمات الاستخدام
  • خريطة الموقع
حقوق النشر © 2025 مجموعة شركات أورغانون. كل الحقوق محفوظة.

You are leaving Organon.com

Cancel Continue Opens a new window

Forward-looking statement of Organon

This news release of Organon (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2020 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov Opens a new window ).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

Decline Accept